Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis

@article{Farris2017PharmacodynamicsOC,
  title={Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis},
  author={M. Farris and C. Bastianelli and Elena Rosato and I. Brosens and G. Benagiano},
  journal={Expert Review of Clinical Pharmacology},
  year={2017},
  volume={10},
  pages={1129 - 1144}
}
  • M. Farris, C. Bastianelli, +2 authors G. Benagiano
  • Published 2017
  • Medicine
  • Expert Review of Clinical Pharmacology
    • ABSTRACT Introduction: The pharmacodynamic effects of various combined oral estrogen-progestin combinations (COC) are examined for their components alone or in the various combined formulations. Special emphasis is given to products containing natural estrogens. Areas covered: Recent information on the effect of androgens, estrogens, progestins, as well as various COC combinations on the coagulation cascade will be reviewed aiming at providing an updated picture. The present article reviews… CONTINUE READING
    View on Taylor & Francis
    ncbi.nlm.nih.gov
    13 Citations
    Highly Influencial Citations
    1
    Background Citations
    2
    13 Citations
    Citation Type

    Citation Type

    Pharmacodynamics of combined estrogen–progestin oral contraceptives: 4. Effects on uterine and cervical epithelia
    • 1
    Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
    • 1
    Effects of low-dose combined oral contraceptives and protein S K196E mutation on anticoagulation factors: a prospective observational study
    • 4
    Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk.
    A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy.
    Blood Hormones and Venous Thromboembolic Events: Lack of Association or Lack of Standardization?
    • PDF
    Mercury induces nuclear estrogen receptors to act as vasoconstrictors promoting endothelial denudation via the PI3K/Akt signaling pathway.
    • 1
    Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?
    • 2
    • PDF
    Contraception for the Cardiac Patient: a Cardiologist’s Primer
    • PDF
    Disorders of Puberty: Pharmacotherapeutic Strategies for Management.
    • M. Zacharin
    • Medicine
    • Handbook of experimental pharmacology
    • 2019
    • 5

    References

    SHOWING 1-10 OF 213 REFERENCES
    Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism
    • 8
    Differential effects of progestins on hemostasis.
    • 43
    Effect of oral contraceptives on haemostasis variables.
    • 175
    • Highly Influential
    Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive
    • 60
    • PDF
    Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
    • 89
    Coagulation effects of oral contraception.
    • J. Bonnar
    • Medicine
    • American journal of obstetrics and gynecology
    • 1987
    • 142
    • Highly Influential
    New progestagens for contraceptive use.
    • 267
    • PDF
    Effects of progestogens on haemostasis.
    • 79
    Estradiol valerate and dienogest: a new approach to oral contraception
    • 16
    • PDF
    A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.
    • 36